Puma Biotechnology PBYI
$7.05 −$0.07 (-0.98%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $7.05 0.00%
Open$7.05
Prev close$7.12
Day range$6.91 – $7.22
Volume861.2K
Market cap$364.47M
P/E (TTM)15.3
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$55.06M+1.1% YoY
Operating profit$5.27M-44.9% YoY
Net profit$5.96M-32.7% YoY
Diluted EPS$0.11-35.3% YoY
Free cash flow$14.58M+50.9% YoY
Operating cash flow$14.58M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin73.6%
Operating margin11.3%
Net margin10.3%
Return on equity18.2%
Return on assets11.7%
Return on invested capital14.6%
Current ratio3.03
Liabilities / assets27.7%
Cash & investments$108.58M
Total debt$4.18M
Net cash (debt)$104.39M
Free cash flow / sales19.9%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $55.06M | $56.50M | $44.81M | $228.37M | $75.45M |
| Total Operating Revenue | $55.06M | $56.50M | $44.81M | $228.37M | $75.45M |
| Cost of Revenue | $15.20M | $12.48M | $10.42M | $58.16M | $23.13M |
| Gross Profit | $39.86M | $44.03M | $34.39M | $170.21M | $52.33M |
| Operating Expense | $34.58M | $36.44M | $38.22M | $132.92M | $35.22M |
| Selling and Admin Expenses | $16.30M | $17.55M | $18.42M | $71.21M | $18.38M |
| -General & Admin Expense | $16.30M | $17.55M | $18.42M | $71.21M | $18.38M |
| Research & Development | $18.28M | $18.90M | $19.80M | $62.07M | $16.84M |
| Asset Impairment Loss | $0.00 | $0.00 | $0.00 | -$362,000.00 | $0.00 |
| Operating Profit | $5.27M | $7.59M | -$3.83M | $37.30M | $17.11M |
| Net Non-Operating Interest Income (Expense) | $879,000.00 | $651,000.00 | $271,000.00 | -$2.54M | -$142,000.00 |
| Non-Operating Interest Income | $879,000.00 | $831,000.00 | $1.00M | $4.08M | $977,000.00 |
| Non-Operating Interest Expense | $0.00 | $180,000.00 | $731,000.00 | $6.62M | $1.12M |
| Other Income (Expense) | $19,000.00 | $9,000.00 | $130,000.00 | $1.03M | $143,000.00 |
| Other Non-Operating Income (Expenses) | $19,000.00 | $9,000.00 | $130,000.00 | $1.03M | $143,000.00 |
| Pretax Profit | $6.17M | $8.25M | -$3.43M | $35.78M | $17.11M |
| Tax | $216,000.00 | $56,000.00 | $326,000.00 | $4.67M | $3.67M |
| Net Profit | $5.96M | $8.19M | -$3.75M | $31.11M | $13.44M |
| Profit from Continuing Operations | $5.96M | $8.19M | -$3.75M | $31.11M | $13.44M |
| Net Income to Parent Company | $5.96M | $8.19M | -$3.75M | $31.11M | $13.44M |
| Net Income to Common Stockholders | $5.96M | $8.19M | -$3.75M | $31.11M | $13.44M |
| Basic EPS | $0.12 | $0.16 | -$0.07 | $0.62 | $0.27 |
| Diluted EPS | $0.11 | $0.16 | -$0.07 | $0.61 | $0.26 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $202.77M | $192.74M | $192.70M | $216.30M | $216.30M |
| Total Current Assets | $157.63M | $145.07M | $142.26M | $162.69M | $162.69M |
| Cash and Cash Equivalents & Short-Term Investments | $108.58M | $93.90M | $101.55M | $97.53M | $97.53M |
| -Cash and Cash Equivalents | $41.55M | $36.54M | $36.19M | $29.64M | $29.64M |
| -Short Term Investments | $67.03M | $57.37M | $65.35M | $67.89M | $67.89M |
| Receivables | $32.83M | $34.06M | $26.33M | $53.65M | $53.65M |
| -Accounts Receivable | $32.83M | $34.06M | $26.33M | $53.65M | $53.65M |
| Prepaid Assets | $2.84M | $2.00M | $1.69M | $1.99M | $1.99M |
| Inventory | $11.49M | $13.32M | $8.69M | $5.52M | $5.52M |
| Restricted Cash | $0.00 | $0.00 | $2.09M | $2.09M | $2.09M |
| Other Current Assets | $1.90M | $1.79M | $1.91M | $1.91M | $1.91M |
| Total Non-Current Assets | $45.14M | $47.66M | $50.44M | $53.62M | $53.62M |
| Net PPE | $4.35M | $4.52M | $4.70M | $5.56M | $5.56M |
| -Gross PPE | $7.28M | $7.43M | $7.59M | $10.16M | $10.16M |
| -Accumulated Depreciation | -$2.93M | -$2.91M | -$2.89M | -$4.60M | -$4.60M |
| Non-Current Prepaid Assets | $97,000.00 | $97,000.00 | $97,000.00 | $101,000.00 | $101,000.00 |
| Goodwill and Other Intangible Assets | $34.09M | $36.52M | $38.96M | $41.39M | $41.39M |
| -Other Intangible Assets | $34.09M | $36.52M | $38.96M | $41.39M | $41.39M |
| Non-Current Deferred Assets | $3.83M | $3.83M | $3.83M | $3.83M | $3.83M |
| Other Non-Current Assets | $2.77M | $2.69M | $2.86M | $2.73M | $2.73M |
| Total Liabilities | $56.15M | $54.19M | $64.28M | $85.96M | $85.96M |
| Total Current Liabilities | $51.97M | $49.83M | $59.74M | $81.25M | $81.25M |
| Payables | $5.06M | $3.11M | $8.17M | $5.06M | $5.06M |
| -Accounts Payable | $5.06M | $3.11M | $8.17M | $5.06M | $5.06M |
| Current Accrued Expenses | $34.30M | $35.99M | $31.16M | $35.86M | $35.86M |
| Short-Term Debt and Capital Lease Obligation | $683,000.00 | $450,000.00 | $11.41M | $23.84M | $23.84M |
| -Current Capital Lease Obligation | $683,000.00 | $450,000.00 | $125,000.00 | $1.31M | $1.31M |
| Other Current Liabilities | $683,000.00 | $1.14M | $1.79M | $2.33M | $2.33M |
| Total Non-Current Liabilities | $4.18M | $4.37M | $4.55M | $4.71M | $4.71M |
| Long Term Debt and Capital Lease Obligation | $4.18M | $4.37M | $4.55M | $4.71M | $4.71M |
| -Long Term Capital Lease Obligation | $4.18M | $4.37M | $4.55M | $4.71M | $4.71M |
| Total Equity | $146.61M | $138.54M | $128.42M | $130.34M | $130.34M |
| Stockholders' Equity | $146.61M | $138.54M | $128.42M | $130.34M | $130.34M |
| Capital Stock | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 |
| -Common Stock | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 |
| Additional Paid-In Capital | $1.42B | $1.42B | $1.42B | $1.41B | $1.41B |
| Retained Earnings | -$1.27B | -$1.28B | -$1.29B | -$1.28B | -$1.28B |
| Gains/Losses Not Affecting Retained Earnings | -$98,000.00 | -$45,000.00 | -$31,000.00 | $36,000.00 | $36,000.00 |
| -Current Debt | – | – | $11.28M | $22.52M | $22.52M |
| Non-Current Accrued Expenses | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $14.58M | $1.62M | $15.42M | $41.80M | $14.42M |
| Net cash flow from continuing operations | $14.58M | $1.62M | $15.42M | $41.80M | $14.42M |
| Net Income from Continuing Operations | $5.96M | $8.19M | -$3.75M | $31.11M | $13.44M |
| Gain/Loss from Continuing Operations | $0.00 | $0.00 | $6,000.00 | $4,000.00 | $0.00 |
| Depreciation & Depletion & Amortization | $2.45M | $2.52M | $2.58M | $10.94M | $2.66M |
| Change in Working Capital | $4.15M | -$11.03M | $14.68M | -$10.08M | -$6.54M |
| -Change in Receivables | $1.23M | -$7.73M | $27.33M | -$21.28M | -$20.09M |
| -Change in Inventory | $1.83M | -$4.63M | -$3.18M | $3.21M | $3.96M |
| -Change in Prepaid Assets | -$1.05M | -$15,000.00 | $116,000.00 | -$325,000.00 | -$718,000.00 |
| -Change in Payables and Accrued Expense | $2.37M | $1.59M | -$8.58M | $12.70M | $11.55M |
| -Change in Other Current Assets | $25,000.00 | -$3,000.00 | $60,000.00 | -$165,000.00 | -$26,000.00 |
| -Change in Other Current Liabilities | -$457,000.00 | -$544,000.00 | -$503,000.00 | -$2.41M | -$672,000.00 |
| -Change In Other Working Capital | $200,000.00 | $300,000.00 | -$553,000.00 | -$1.81M | -$539,000.00 |
| Net cash flow from investing | -$9.71M | $7.97M | $2.47M | -$36.19M | -$26.98M |
| Net Cash Flow from Continuing Investing Activities | -$9.71M | $7.97M | $2.47M | -$36.19M | -$26.98M |
| Net PPE Purchase and Sale | $0.00 | $0.00 | $0.00 | -$71,000.00 | $36,000.00 |
| Net Investment Purchase and Sale | -$9.71M | $7.97M | $2.47M | -$36.12M | -$27.01M |
| Financing Cash Flow | $146,000.00 | -$11.34M | -$11.33M | -$45.20M | -$11.33M |
| Net Cash Flow from Continuing Financing Activities | $146,000.00 | -$11.34M | -$11.33M | -$45.20M | -$11.33M |
| Net Issuance Payments Of Debt | $0.00 | -$11.12M | -$11.11M | -$44.44M | -$11.11M |
| Proceeds from Stock Option Exercised | $146,000.00 | – | – | $130,000.00 | $0.00 |
| Net Other Financing Charges | $0.00 | -$223,000.00 | -$222,000.00 | -$888,000.00 | -$222,000.00 |
| Ending Cash Balance | $41.55M | $36.54M | $38.28M | $31.73M | $31.73M |
| Net Change in Cash | $5.01M | -$1.75M | $6.56M | -$39.58M | -$23.89M |
| Beginning Cash Balance | $36.54M | $38.28M | $31.73M | $71.31M | $55.62M |
| Free Cash Flow | $14.58M | $1.62M | $15.42M | $41.73M | $14.46M |
| Deferred Tax | – | – | – | $3.25M | – |
| Net Intangibles Purchase and Sale | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on PBYI.
Sign in to join the discussion.